Leqembi, first drug that slows Alzheimer’s, gets full FDA approval
Editor in Chief at The Newz Radar
Latest posts by Sunil Chadda (see all)
- 3 upper floors at Sanjauli mosque declared illegal by Shimla MC court, need to be demolished - October 5, 2024
- Shimla MC Court orders demolition of 3 illegal floors of Sanjauli mosque - October 5, 2024
- Pensioners gherao Himachal minister Anirudh Singh in Shimla over non-payment of pension - October 5, 2024
The Newz Radar
Leqembi, the first drug proven to slow the progression of Alzheimer’s disease, was granted full approval from US Food and Drug Administration on Thursday. With this, Medicare and other insurance plans can now cover Alzheimer’s treatment. Leqembi is priced at about $26,500 for a year. It was found to clear amyloid plaque buildup in brain associated with the memory-robbing disease.
